AORT (STOCKS)
Artivion, Inc.
$39.628000
+1.998000 (+5.31%)
Prev close: $37.630000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- James Patrick Mackin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,846.40M
- Employees
- 1,600
- P/E (TTM)
- 181.88
- P/B (TTM)
- 4.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.05 | $0.08 | -0.0333 | -39.98% |
|
Sep 2025 (Q3)
|
$0.06 | $0.02 | +0.0425 | +242.86% |
|
Jun 2025 (Q2)
|
$0.08 | $0.00 | +0.0844 | +1,918.18% |
|
Mar 2025 (Q1)
|
$-0.01 | $-0.12 | +0.1107 | +91.72% |
Financial Statements
| Revenues | $441.33M |
| Benefits Costs and Expenses | $426.55M |
| Cost Of Revenue | $157.10M |
| Costs And Expenses | $426.55M |
| Gross Profit | $284.23M |
| Operating Expenses | $257.48M |
| Selling, General, and Administrative Expenses | $226.49M |
| Research and Development | $30.99M |
| Operating Income/Loss | $33.75M |
| Income/Loss From Continuing Operations After Tax | $9.77M |
| Income/Loss From Continuing Operations Before Tax | $14.78M |
| Income Tax Expense/Benefit | $5.01M |
| Income Tax Expense/Benefit, Current | $4.98M |
| Income Tax Expense/Benefit, Deferred | $37.00K |
| Net Income/Loss | $9.77M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $9.77M |
| Net Income/Loss Available To Common Stockholders, Basic | $9.76M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $22.00K |
| Preferred Stock Dividends And Other Adjustments | $11.00K |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | $11.00K |
| Basic Earnings Per Share | $0.22 |
| Diluted Earnings Per Share | $0.21 |
| Basic Average Shares | 45,335,000 |
| Diluted Average Shares | 47,162,000 |
| Assets | $884.80M |
| Current Assets | $358.08M |
| Inventory | $92.43M |
| Other Current Assets | $265.66M |
| Noncurrent Assets | $526.71M |
| Fixed Assets | $64.99M |
| Other Non-current Assets | $461.73M |
| Liabilities | $436.56M |
| Current Liabilities | $101.56M |
| Accounts Payable | $16.04M |
| Wages | $22.48M |
| Other Current Liabilities | $63.03M |
| Noncurrent Liabilities | $335.01M |
| Long-term Debt | $215.11M |
| Other Non-current Liabilities | $119.89M |
| Equity | $448.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $448.23M |
| Liabilities And Equity | $884.80M |
| Net Cash Flow From Operating Activities | $39.88M |
| Net Cash Flow From Operating Activities, Continuing | $39.88M |
| Net Cash Flow From Investing Activities | -$42.04M |
| Net Cash Flow From Investing Activities, Continuing | -$42.04M |
| Net Cash Flow From Financing Activities | $11.28M |
| Net Cash Flow From Financing Activities, Continuing | $11.28M |
| Exchange Gains/Losses | $2.32M |
| Net Cash Flow | $11.45M |
| Net Cash Flow, Continuing | $9.12M |
| Comprehensive Income/Loss | $31.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $31.98M |
| Other Comprehensive Income/Loss | $31.98M |